Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17 USD | -0.53% | +6.78% | -3.74% |
Apr. 25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
Financials (USD)
Sales 2024 * | 535M | Sales 2025 * | 577M | Capitalization | 797M |
---|---|---|---|---|---|
Net income 2024 * | 43M | Net income 2025 * | 57M | EV / Sales 2024 * | 1.74 x |
Net Debt 2024 * | 132M | Net Debt 2025 * | 79M | EV / Sales 2025 * | 1.52 x |
P/E ratio 2024 * |
18.9
x | P/E ratio 2025 * |
14.1
x | Employees | 3,500 |
Yield 2024 * |
0.24% | Yield 2025 * |
0.24% | Free-Float | 98.99% |
Latest transcript on Core Laboratories Inc.
1 day | -0.53% | ||
1 week | +6.78% | ||
Current month | +7.59% | ||
1 month | -3.57% | ||
3 months | +17.08% | ||
6 months | -12.24% | ||
Current year | -3.74% |
Managers | Title | Age | Since |
---|---|---|---|
Lawrence Bruno
CEO | Chief Executive Officer | 64 | - |
Christopher Hill
DFI | Director of Finance/CFO | 54 | - |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Curtis Anastasio
BRD | Director/Board Member | 67 | 23-06-27 |
Director/Board Member | 71 | 19-12-31 | |
Director/Board Member | 74 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 17 | -0.53% | 421,327 |
24-05-09 | 17.09 | +3.95% | 326,416 |
24-05-08 | 16.44 | +2.24% | 296,294 |
24-05-07 | 16.08 | +0.12% | 223,870 |
24-05-06 | 16.06 | +0.88% | 263,468 |
Delayed Quote Nyse, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.74% | 797M | |
0.00% | 7.34B | |
-11.55% | 2.91B | |
-10.79% | 2.74B | |
-29.59% | 1.79B | |
-0.07% | 1.19B | |
-6.77% | 1.07B | |
-10.71% | 834M | |
-13.46% | 772M | |
+0.21% | 758M |
- Stock Market
- Equities
- CLB Stock